Ayanin, a flavonoid extracted from red wine grapes, has demonstrated efficacy in ameliorating hyperglycemia, dyslipidemia, and insulin resistance through directly targeting the AMPKα/GLUT4 and AMPKα/CPT‐1α signaling pathways in metabolic tissues. The gene discussed is SLC2A4; the disease is Hyperglycemia.